When responding to an ad for a job caring for patient-detainees along the US southern border, applicants should anticipate the need to navigate dual loyalties.
AMA J Ethics. 2021; 23(1):E12-17. doi:
10.1001/amajethics.2021.12.
Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.
AMA J Ethics. 2016; 18(3):279-287. doi:
10.1001/journalofethics.2016.18.3.pfor4-1603.
Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research.
AMA J Ethics. 2021; 23(9):E685-691. doi:
10.1001/amajethics.2021.685.
Editorial fellow Dr Ariel Wampler describes what few know about material and device regulation, and Dr Adriane Fugh-Berman explains why we should ask more questions about device representatives’ intraoperative roles during implantations.
Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?"
Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020; 22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Rachel Koch, MD, John G. Meara, MD, DMD, MBA, and Anji E. Wall, MD, PhD
Single-procedure interventions with minimal follow-up and clear quality-of-life gain are well suited for surgical mission trips. But not all risks and benefits are easily assessed.
AMA J Ethics. 2019; 21(9):E729-734. doi:
10.1001/amajethics.2019.729.